At a glance
- Originator Eli Lilly and Company
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 20 Mar 1996 Discontinued profile.
- 20 Mar 1996 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)